Easterly Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,060	Closed	-$367K	–	202
2024 Q1	$367K	Sell	1,060 -15,597	-94%	-$5.13M	0.03%	186
2023 Q4	$5.38M	Sell	16,657 -18,070	-52%	-$5.66M	0.58%	64
2023 Q3	$12.4M	Sell	34,727 -9,319	-21%	-$3.6M	1.37%	17
2023 Q2	$16.7M	Buy	44,046 +2,919	+7%	+$1.19M	1.49%	16
2023 Q1	$19.7M	Sell	41,127 -28,350	-41%	-$13.3M	1.74%	8
2022 Q4	$29.2M	Buy	69,477 +16,419	+31%	+$6.63M	2.53%	2
2022 Q3	$22.1M	Buy	53,058 +3,601	+7%	+$1.8M	2.12%	8
2022 Q2	$24.5M	Buy	49,457 +13,678	+38%	+$7.12M	2.18%	6
2022 Q1	$20.2M	Buy	35,779 +33,907	+1,811%	+$20.4M	1.53%	18
2021 Q4	$1.41M	Buy	1,872 +32	+2%	+$23.9K	0.1%	126
2021 Q3	$1.37M	Hold	1,840	–	–	0.09%	128
2021 Q2	$1.19M	Hold	1,840	–	–	0.14%	57
2021 Q1	$1.05M	Hold	1,840	–	–	0.13%	53
2020 Q4	$1.07M	Sell	1,840 -1,418	-44%	-$808K	0.15%	51
2020 Q3	$1.68M	Sell	3,258 -9	-0.3%	-$4.56K	0.07%	42
2020 Q2	$1.48M	Sell	3,267 -103,146	-97%	-$45.5M	0.07%	43
2020 Q1	$37.3M	Sell	106,413 -57,745	-35%	-$21.2M	1.65%	26
2019 Q4	$60.7M	Sell	164,158 -108,996	-40%	-$38.4M	1.71%	27
2019 Q3	$90.9M	Sell	273,154 -368,654	-57%	-$120M	2.55%	17
2019 Q2	$201M	Buy	641,808 +55,191	+9%	+$16.5M	5.04%	1
2019 Q1	$179M	Buy	+586,617	New	+$158M	4.33%	6